Top 10 Medical Schools In The World 2013
Written by Shukti Sarma
#1. Harvard School of Medicine
It goes without saying that Harvard is on of the most prestigious brands to reckon with, and in terms of research, it is the most trusted institution. The Academic Ranking Of World Universities, an annual ranking of the world's universities published from Shanghai Jiao Tong University in China, recently named Harvard as the top medical school in the world. The school has a large and distinguished faculty to support its missions of education, research, and clinical care. Harvard also has a distinguished list of teaching affiliates, and its alumni include some of the most respected names in medicine. Its MD-PhD program allows a student to receive an M.D. from HMS and a Ph.D. from either Harvard or the Massachusetts Institute of Technology under its famous Medical Scientist Training Program. The MD programme offers two tracks - the New Pathway, that emphasizes problem-based learning, while the Harvard-MIT Division of Health Sciences and Technology focuses on research.
#2. John Hopkins University
John Hopkins School of Medicines consistently ranks among the top medical schools in the world. It gets the maximum number of competitive research grants awarded by the National Institutes of Health, and from 1991-2001, the John Hopkins hospital has been named the best in the country by US News and World Report.
#3. University of California
The University of California, San Francisco is one of the best names in primary care. UCLA is well known for research in AIDS, family medicine and drug and alcohol abuse. The UCLA medical centre ranks among the top medical specialty areas, and is named one of the best hospitals in the country.
#4. University of North Carolina, Chapel Hill
The US News and World Report ranks it as the best place to study primary care, and is one of the premier institutes to study rural care. One of the original Ivy League Universities, it is a prominent name in cancer research.
#5. Stanford University
One of the oldest medical schools in the country, Stanford University School of Medicine is synonymous with innovation, and is a premier institute for biomedical research. Students also manage two free clinics, and the school lays emphasis on serving the underserved sections of the society.
#6. University of Cambridge
The School of Clinical Medicine is one of the best in the world, and half the training is provided at the famous Addenbrooke's Hospital site. Most seats are for British students, while some overseas students are accepted. It is one of the most prestigious schools in the world, and the selection procedure is extremely tough.
#7. University of Michigan, Ann Arbor
Counted not only among the best research and primary care institutes, it is known for internal medicine, women’s health and geriatrics. The vast University of Michigan Health System provides immense opportunities for learning and practical experience.
#8. Columbia University
The first university in the US to grant an MD degree, and is one of the most selective institutes in the world. The academic medical centre has four schools - each ranking within the top five in its area. The college for physicians and surgeons is currently ranked 5th amongst medical schools in the world by the Academic Ranking of World Universities.
#9. Karolinska Institute
No list is complete without considering the institution that awards the Nobel Prize. It is one of Sweden's largest centres for training and research, and according to the 2011 Academic Ranking of World Universities, Karolinska Institute is ranked 9th in the world in the field of clinical medicine and pharmacology and among the first 20 universities in life sciences.
#10. Duke University
It counts among the top three institutes for medical research in the US, and students can learn and seize the opportunities that the Duke University Health System offers. It consistently ranks among the top 10 medical schools and hospitals.
Top 10 healthcare innovations for 2019
We take a look at some of the top 10 healthcare innovations which are transforming the sector
The telehealth market is booming. Consumers are leading increasingly busy lifestyles, with up to 60% favouring digitally-led services. Providing clinical care at a distance, increasing accessibility and eradicating potential delays has given patients greater control, boosting patient satisfaction and overall engagement. Such is its exponential growth, The Centers for Medicare and Medicaid Services in the US has recently released its proposed Physician Fee Schedule and Qualified Payment Programme updates for 2019, where telehealth services has been heavily featured, in order to deliver ‘different access points’ for patients.
9. Mobile technology
Consumers have become accustomed to accessing their data through the use of various digital tools, where the use of mobile and tablet health apps has tripled from 13% in 2014 to 48% today. Catering to this growing market, British based start-up Babylon Health is making waves on a global scale. Partnering with the National Health Service (NHS) and private health provider, Bupa, it has also cemented its presence across the flourishing Chinese market, with a membership base exceeding 1.4mn citizens across Europe, Asia and Africa. By partnering with global juggernaut Tencent, Babylon’s artificial intelligence system has enabled both parties to interact directly with users, identify specific illnesses, deliver health status assessments, and triage necessary actions. The mobile app is available to over a billion users and linked to more than 38,000 medical facilities in China alone.
8. Artificial intelligence
Artificial intelligence (AI) applications, such as predictive analytics for patient monitoring has provided significant financial savings. Applications that target hospitals and medical institutions include patient monitoring and transcribing notes for electronic health records (EHRs). The European Union is set to invest $24bn into artificial intelligence (AI) by 2020 in a bid to catch up with Asia and the US, who have invested heavily in AI and cloud services. This year, Google revealed its plans to harness AI and machine learning across a multitude of consumer technologies, particularly in healthcare. “If AI can shape healthcare, it has to work through the regulations of healthcare. In fact, I see that as one of the biggest areas where the benefits will play out for the next 10-20 years,” Google CEO Sundar Pichai has previously stated.
Blockchain is estimated to reach over $5.61bn by the end of 2025, even though it remains dependent on the ability to record and store information conveniently, economically and securely amongst different applications and systems. Providing transparency and eliminating third-party intermediaries, processes are streamlined, reducing healthcare costs exponentially. Unlocking the ability for providers to deliver a value-based healthcare system and enhance patient engagement, blockchain could save the industry up to $100-$150bn per year by 2025 in data breach-related costs, IT costs, operations costs, support function costs and personnel costs, according to BIS Research. Partnering with pharmaceutical giant GlaxoSmithKline (GSK), Ethereum blockchain-based supply chain platform, Viant sought to accelerate the pace of blockchain-based supply chain systems. Accenture and supply chain giant DHL have also developed a blockchain-based serialisation prototype which tracks pharmaceuticals from the point of origin to the consumer.
6. Health wearables
With the rise of lifestyle diseases, such as diabetes, more consumers are turning to health wearables that monitor glucose, heart rate, physical activity and sleep to gain a greater understanding of their health conditions. Following on from the release of the first Bluetooth headset back in 2000, the growing interest in wearables has seen monitoring our health and data become standardised. This data can be analysed by sophisticated algorithms to drive long-term diagnosis and support. Partnering with Google, health wearables company Fitbit is exploring the development of consumer and enterprise health solutions. Its acquisition of HIPAA-compliant health platform, Twine Health has seen the business enhance its clinical services by bringing on board a coaching platform, empowering people to seek better health outcomes.
- Novartis Social Business: Blending profit with purpose
- How Microsoft is transforming Canada's healthcare
- The December edition of Healthcare Global is live!
5. Electronic health records tools
From 2018-2022, the electronic health records (EHR) market is expected to grow at a compound average rate of 6% per year Providers and organisations continue to house fragmented technologies which create barriers towards collaboration and data sharing opportunities. This is further exacerbated if a patient straddles both public and private healthcare. Technology giant Apple has integrated patients’ medical records into its Health App as part of its iOS 11.3 beta. The data is encrypted and protected with the user’s iPhone passcode. Partnering with hospital providers and clinics, patients are now able to view their medical records from multiple providers within one platform. Johns Hopkins Medicine, Cedars-Sinai, Penn Medicine, UC San Diego Health and even the Cleveland Clinic have implemented this technology.
4. Healthcare transportation
Non-emergency health transportation remains a key issue worldwide, preventing patients from getting to or from a doctor’s appointment. 25% of lower-income patients have missed or rescheduled appointments due to lack of transportation, costing US health systems up to $150bn each year. Transportation companies such as Lyft and Uber have therefore entered the market by partnering with state governments to reduce these costs and deliver personalised patient care.
3. 3D Printing
Healthcare providers are set to represent the second largest industry sector in 3D manufacturing. The Food & Drug Administration’s decision to release its first comprehensive framework advising manufacturers of 3D medical products highlights its growing impact where more than 100,000 knee replacement surgeries are completed each year using 3D-printed, patient-matched surgical guides, for example. Through this process, surfaces and structures can be optimised for strength, weight and material use. Consultation between surgeons and patients has also been bolstered, where patients can better understand the complexity of his or her specific needs.
As consumers get more involved in the management of their health, consumer genetics and research companies have grown in popularity and scale. People want to further understand their genetic makeup, leading personal genomics and biotech company 23andMe to become one of the largest consumer-based organisations worldwide. Interestingly, this year, the company has entered a four-year collaboration with GSK to develop new treatments, but using human genetics as the basis for discovery.
Not only looking to develop treatments by analysing human genetics, pharmaceutical companies are looking to even remove hereditary genes which pass diseases down generations. In 2017, human embryos were successfully ‘edited’ through gene editing tool, CRISPR (Clustered, Regularly Interspaced, Short Palindromic Repeats), eradicating hypertrophic cardiomyopathy within 42 embryos.
1. Vertical integrations
As healthcare providers aim to provide greater transparency, promote collaboration and lower escalating patient costs, 2018 has been the year for a significant number of vertical integrations. CVS Health’s $68mn takeover of health insurer Aetna is a case in point. By influencing more of the supply chain, it will gain significant negotiating power to reduce costs for payers and patients, develop personalised solutions and improve overall outcomes. It will also promote the eradication of delays in process by removing any third parties within traditional business models. Other notable integrations are Optum’s acquisition of the DaVita Medical Group, Humana and Kindred Healthcare and Cigna and Express Scripts.
Reports have indicated that not only has the number of healthcare deals more than doubled in the last five years, the size of deals has also grown as a result of repeat investor interest, highlighting that this trend is here to stay.